1 Coppé JP, "The senescence-associated secretory phenotype : the dark side of tumor suppression" 5 : 99-118, 2010
2 Min LJ, "Signaling mechanisms of angiotensin II in regulating vascular senescence" 8 : 113-121, 2009
3 Baker DJ, "Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency" 10 : 825-836, 2008
4 민세희, "Independent Association of Serum Aldosterone Level with Metabolic Syndrome and Insulin Resistance in Korean Adults" 대한심장학회 48 (48): 198-208, 2018
5 Campisi J, "Cellular senescence : when bad things happen to good cells" 8 : 729-740, 2007
6 Welch WJ, "Angiotensin II-dependent superoxide : effects on hypertension and vascular dysfunction" 52 : 51-56, 2008
7 Kunieda T, "Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway" 114 : 953-960, 2006
8 Inho Kim, "Angiotensin II Type 1 Receptor Blocker, Fimasartan, Reduces Vascular Smooth Muscle Cell Senescence by Inhibiting the CYR61 Signaling Pathway" 대한심장학회 49 (49): 615-626, 2019
9 Campisi J, "Aging, cellular senescence, and cancer" 75 : 685-705, 2013
10 Shay JW, "A role for both RB and p53 in the regulation of human cellular senescence" 196 : 33-39, 1991